Pharmaceuticals in Japan

Date: June 30, 2017
Pages: 39
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P4124EA33C6EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Japan
Pharmaceuticals in Japan

SUMMARY

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

SYNOPSIS

Essential resource for top-line data and analysis covering the Japan pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

KEY HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
  • The Japanese pharmaceuticals market had total revenues of $70.0bn in 2016, representing a compound annual rate of change (CARC) of -0.2% between 2012 and 2016.
  • In Japan, every citizen is required to participate in the National Health Insurance (NHI) scheme and the majority of health care spending is publically funded through this and other government funds.
  • In April 2016, a new Health Technology Assessment (HTA) system was introduced, as a pilot program focused on the re-pricing of seven drugs and six medical devices that had been launched in previous years.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
REASONS TO BUY
  • What was the size of the Japan pharmaceuticals market by value in 2016?
  • What will be the size of the Japan pharmaceuticals market in 2021?
  • What factors are affecting the strength of competition in the Japan pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Japan's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Astellas Pharma Inc.
Daiichi Sankyo Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Company Limited
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Japan pharmaceuticals market value: $ billion, 2012–16
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: Japan pharmaceuticals market share: % share, by value, 2016
Table 4: Japan pharmaceuticals market value forecast: $ billion, 2016–21
Table 5: Astellas Pharma Inc.: key facts
Table 6: Astellas Pharma Inc.: key financials ($)
Table 7: Astellas Pharma Inc.: key financials (¥)
Table 8: Astellas Pharma Inc.: key financial ratios
Table 9: Daiichi Sankyo Co., Ltd.: key facts
Table 10: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 11: Daiichi Sankyo Co., Ltd.: key financials (¥)
Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 13: Mitsubishi Tanabe Pharma Corporation: key facts
Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (¥)
Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 17: Takeda Pharmaceutical Company Limited: key facts
Table 18: Takeda Pharmaceutical Company Limited: key financials ($)
Table 19: Takeda Pharmaceutical Company Limited: key financials (¥)
Table 20: Takeda Pharmaceutical Company Limited: key financial ratios
Table 21: Japan size of population (million), 2012–16
Table 22: Japan gdp (constant 2005 prices, $ billion), 2012–16
Table 23: Japan gdp (current prices, $ billion), 2012–16
Table 24: Japan inflation, 2012–16
Table 25: Japan consumer price index (absolute), 2012–16
Table 26: Japan exchange rate, 2012–16

LIST OF FIGURES

Figure 1: Japan pharmaceuticals market value: $ billion, 2012–16
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 3: Japan pharmaceuticals market share: % share, by value, 2016
Figure 4: Japan pharmaceuticals market value forecast: $ billion, 2016–21
Figure 5: Forces driving competition in the pharmaceuticals market in Japan, 2016
Figure 6: Drivers of buyer power in the pharmaceuticals market in Japan, 2016
Figure 7: Drivers of supplier power in the pharmaceuticals market in Japan, 2016
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2016
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2016
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2016
Figure 11: Astellas Pharma Inc.: revenues & profitability
Figure 12: Astellas Pharma Inc.: assets & liabilities
Figure 13: Daiichi Sankyo Co., Ltd.: revenues & profitability
Figure 14: Daiichi Sankyo Co., Ltd.: assets & liabilities
Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability
Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities
Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability
Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities

COMPANIES MENTIONED

Astellas Pharma Inc.
Daiichi Sankyo Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Company Limited
Skip to top


OTC Pharmaceuticals in Japan US$ 350.00 Sep, 2016 · 35 pages

Ask Your Question

Pharmaceuticals in Japan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: